These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Kumar P; Liu C; Hsu JW; Chacko S; Minard C; Jahoor F; Sekhar RV Clin Transl Med; 2021 Mar; 11(3):e372. PubMed ID: 33783984 [TBL] [Abstract][Full Text] [Related]
5. Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine. Behr J; Degenkolb B; Krombach F; Vogelmeier C Eur Respir J; 2002 May; 19(5):906-11. PubMed ID: 12030732 [TBL] [Abstract][Full Text] [Related]
6. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients. Nur E; Brandjes DP; Schnog JJ; Otten HM; Fijnvandraat K; Schalkwijk CG; Biemond BJ; Br J Haematol; 2010 Oct; 151(1):62-9. PubMed ID: 20678158 [TBL] [Abstract][Full Text] [Related]
7. A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine. Krysko KM; Bischof A; Nourbakhsh B; Henry RG; Revirajan N; Manguinao M; Nguyen K; Akula A; Li Y; Waubant E Ann Clin Transl Neurol; 2021 Apr; 8(4):811-824. PubMed ID: 33675156 [TBL] [Abstract][Full Text] [Related]
8. Potential utility of melatonin as an antioxidant therapy in the management of sickle cell anemia. da Silva DG; Ricci O; de Almeida EA; Bonini-Domingos CR J Pineal Res; 2015 Mar; 58(2):178-88. PubMed ID: 25545035 [TBL] [Abstract][Full Text] [Related]
9. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959 [TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system. Rodrigues SD; França KC; Dallin FT; Fujihara CK; Nascimento AJ; Pecoits-Filho R; Nakao LS Life Sci; 2015 Jan; 121():110-6. PubMed ID: 25500303 [TBL] [Abstract][Full Text] [Related]
11. Modulatory effect of N-acetylcysteine on pro-antioxidant status and haematological response in healthy men. Zembron-Lacny A; Slowinska-Lisowska M; Szygula Z; Witkowski Z; Szyszka K J Physiol Biochem; 2010 Mar; 66(1):15-21. PubMed ID: 20354834 [TBL] [Abstract][Full Text] [Related]
12. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial. Alfonso H; Franklin P; Ching S; Croft K; Burcham P; Olsen N; Reid A; Joyce D; de Klerk N; Musk AB Respirology; 2015 Oct; 20(7):1102-7. PubMed ID: 26172395 [TBL] [Abstract][Full Text] [Related]
13. Monocytosis is associated with hemolysis in sickle cell disease. Wongtong N; Jones S; Deng Y; Cai J; Ataga KI Hematology; 2015 Dec; 20(10):593-7. PubMed ID: 25875078 [TBL] [Abstract][Full Text] [Related]
14. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease. Nolin TD; Ouseph R; Himmelfarb J; McMenamin ME; Ward RA Clin J Am Soc Nephrol; 2010 Sep; 5(9):1588-94. PubMed ID: 20538838 [TBL] [Abstract][Full Text] [Related]
15. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage. Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979 [TBL] [Abstract][Full Text] [Related]
17. Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. Roes EM; Raijmakers MT; Boo TM; Zusterzeel PL; Merkus HM; Peters WH; Steegers EA Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):61-7. PubMed ID: 16243427 [TBL] [Abstract][Full Text] [Related]
18. Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer. Visacri MB; Quintanilha JCF; de Sousa VM; Amaral LS; de F L Ambrósio R; Calonga L; Curi SFBB; de T Leme MF; Chone CT; Altemani JMC; Mazzola PG; Malaguti C; Vercesi AE; Lima CSP; Moriel P Cancer Med; 2019 May; 8(5):2020-2030. PubMed ID: 30977273 [TBL] [Abstract][Full Text] [Related]
19. N-Acetyl cysteine (NAC) inhibits proliferation, collagen gene transcription, and redox stress in rat palatal mucosal cells. Sato N; Ueno T; Kubo K; Suzuki T; Tsukimura N; Att W; Yamada M; Hori N; Maeda H; Ogawa T Dent Mater; 2009 Dec; 25(12):1532-40. PubMed ID: 19679343 [TBL] [Abstract][Full Text] [Related]
20. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study. Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]